Michael Hewera

Heinrich Heine University Düsseldorf

Papers

1

Total Citations

16

H-Index

1

About

Michael Hewera is a pioneering researcher at the intersection of robotics and neuro-oncology, whose work leverages automated technology to uncover novel therapeutic strategies for glioblastoma. His most-cited study, "Robot technology identifies a Parkinsonian therapeutics repurpose to target stem cells of glioblastoma" (2020, 16 citations), exemplifies his innovative approach. In this landmark paper, Hewera programmed a robotic workstation to conduct high-throughput drug screening, successfully identifying a repurposed Parkinson’s drug that selectively targets glioblastoma stem cells—the root of the tumor’s heterogeneity and lethality. By integrating artificial intelligence-driven automation with stem cell biology and neurotransmitter microenvironment analysis, he has opened new avenues for precision medicine in one of the most aggressive brain cancers. Hewera’s work demonstrates how interdisciplinary methods can address critical clinical needs, offering a scalable platform for discovering therapies that attack cancer at its cellular source. His contributions are particularly notable for bridging engineering and oncology, showcasing the power of robotics to accelerate drug repurposing and transform treatment paradigms for patients with limited options.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Robot technology identifies a Parkinsonian therapeutics repurpose to target stem cells of glioblastoma
16 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Heinrich Heine University Düsseldorf

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago